BNP PARIBAS FINANCIAL MARKETS - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$491,869
+25.2%
242,300
+41.9%
0.00%
Q2 2023$392,780
+51.4%
170,774
+99.5%
0.00%
Q1 2023$259,380
+454.8%
85,604
+326.6%
0.00%
Q4 2022$46,751
-99.9%
20,065
-48.1%
0.00%
Q3 2022$73,856,000
+14.3%
38,668
+62.2%
0.00%
Q2 2022$64,596,000
+180.0%
23,836
+207.8%
0.00%
Q1 2022$23,074,000
-76.1%
7,743
-68.8%
0.00%
Q4 2021$96,690,000
+43.1%
24,856
+57.8%
0.00%
Q3 2021$67,589,000
+246.5%
15,755
+144.8%
0.00%
Q2 2021$19,504,000
+177209.1%
6,437
+107183.3%
0.00%
Q2 2020$11,000
-84.5%
6
-91.4%
0.00%
Q1 2020$71,000
-63.6%
700.0%0.00%
Q4 2019$195,000
-96.8%
70
-98.2%
0.00%
Q3 2019$6,042,000
-26.7%
3,9620.0%0.00%
Q2 2019$8,241,000
-68.7%
3,962
-46.1%
0.00%
Q1 2019$26,302,000
+141.0%
7,347
+536.1%
0.00%
Q3 2018$10,915,000
+29.4%
1,1550.0%0.00%
Q2 2018$8,432,0001,1550.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders